-
Vaccines and Neurodegeneration: Lessons for Huntington’s Disease?
Latest News
-
UniQure Secures Type A Meeting with FDA: What This Means for AMT-130
⏱️6 min read | UniQure secured a Type A FDA meeting, a high-priority discussion for urgent issues. Within 30 days, both sides will discuss what kind of data package might support the advancement of AMT-130 in the US.
-
Oz Buzz Video: Day 2
The final day of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-
Oz Buzz Video: Day 1
Day 1 of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-
Oz Buzz Updates: Day 3
Day 3 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-
Oz Buzz Updates: Day 2
Day 2 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-
Oz Buzz Updates: Day 1
Day 1 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-
Stand By for Oz Buzz
Follow @HDBuzzFeed and send your questions for the World Congress on Huntington's disease
-
Ten golden rules for reading a scientific news story
Avoid the hype: HDBuzz presents ten 'golden rules' for reading a news story or press release about Huntington's disea
-
Protein-folding drug helps HD mice… for a while
A drug that activates an ancient cellular defense mechanism slows down HD in mice – but why didn’t the benefit last?
-
A back-to-front hidden message in the HD gene?
Unzip your genes! A backwards message, hidden in the 'backup DNA' of the Huntington's disease gene… what does it me
-
Stem cells and HD: past, present and future
Stem cells – who needs 'em? Scientists make brain cells from skin cells. Could this help HD?
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
